Hemab Therapeutics Holdings Common Stock Accounts Payable

Hemab Therapeutics Holdings Common Stock (COAG) currently reports a accounts payable of $6.2M as of June 2026. Use the charts on this page to explore Hemab Therapeutics Holdings Common Stock's accounts payable history and peer comparisons.

Hemab Therapeutics Holdings Common Stock reported $6.2M in accounts payable as of June 2026. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $6.2M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Hemab Therapeutics Holdings Common Stock, and consider following COAG for alerts when major investors trade the stock.

Hemab Therapeutics Holdings Common Stock is classified in the Healthcare sector. On accounts payable, it currently shows $6.2M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing COAG with unrelated industries.